WARSAW, Ind. – Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a prominent global medical technology company, has announced its Board of Directors has approved a quarterly cash dividend for the first quarter of 2025.
The dividend, set at $0.24 per share, is scheduled to be paid on or around April 30, 2025, to stockholders of record as of the close of business on March 31, 2025.
About Zimmer Biomet
Zimmer Biomet is a leading medical technology company, offering a diverse range of products designed to enhance mobility and improve overall health. The company integrates innovative digital and robotic technologies, including data analysis and artificial intelligence, to improve the patient experience. With a history of over 90 years, Zimmer Biomet focuses on providing high-quality solutions for both patients and healthcare providers. The company operates in over 25 countries worldwide and has sales in over 100 countries, demonstrating a commitment to innovation and progress.
For additional information about Zimmer Biomet’s product portfolio, international operations, or career opportunities, visit www.zimmerbiomet.com or connect via LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
Contact:
- Media: Heather Zoumas-Lubeski, 445-248-0577, [email protected]
- Investors:
- David DeMartino, 646-531-6115, [email protected]
- Zach Weiner, 908-591-6955, [email protected]
